Tofacitinib
Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM in cell-free assays, 20- to 100-fold less potent against JAK2 and JAK1. Tofacitinib inhibits the expression of antiapoptotic BCL-A1 and BCL-XL in human plasmacytoid dendritic cells (PDC) and induced PDC apoptosis.
| Trivial name | CP-690550, Tasocitinib |
| Catalog Number | S2789 |
| Molecular Formula | C36H56O8 |
| CAS# | 477600-75-2 |
| Inchi | InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1 -6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1 |
| Inchi Key | PHEDXBVPIONUQT-RGYGYFBISA-N |
| SMILES | CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C |
| Size | 100mg |
| Supplier Page | http://www.selleckchem.com/products/tofacitinib-cp-690550.html |
| Additional Information | https://file.selleck.cn/downloads/struct/CP-690550-chemical-structure-s2789.gif |